Bill

Bill > S1691


NJ S1691

Requires health insurers to cover Lyme disease.


summary

Introduced
02/28/2022
In Committee
02/28/2022
Crossed Over
Passed
Dead
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

This bill requires health insurers (health, hospital and medical service corporations; commercial individual and group health insurers; health maintenance organizations; health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs; the State Health Benefits Program; and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the treatment of Lyme Disease. Treatment otherwise eligible for benefits pursuant to this bill may not be denied solely because such treatment may be characterized as experimental or investigational in nature.

AI Summary

This bill requires health insurers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurers, health maintenance organizations, and state and school employee health benefits programs, to provide coverage for the treatment of Lyme disease that is determined to be medically necessary by the covered person's physician. The bill also states that treatment cannot be denied solely because it is considered experimental or investigational in nature. The bill will take effect 90 days after it is enacted.

Committee Categories

Business and Industry

Sponsors (2)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 02/28/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...